Coronary Artery Disease Clinical Trial
Official title:
The Evaluation of Fractional Flow Reserve and D SPECT for the Intervention of Chronic Total Occlusion
Coronary chronic total occlusions (CTOs) are defined as an occluded coronary vessel with TIMI defined as an occluded coronary vessel with TIMI (Thrombolysis in Myocardial Infarction) grade flow 0 and an estimated duration of at least 3 months. They are frequently encountered in patients undergoing coronary angiography. The application of contemporary techniques and the use of advanced dedicated equipment lead to high procedural success and low adverse events rates in experienced centers. Fractional flow reserve (FFR) is a validated tool to assess physiological severity of coronary artery disease and have a prognostic role after percutaneous coronary intervention (PCI). SPECT (Single-Photon Emission Computed Tomography) is the golden standard for detection of myocardial ischemia. Recanalization of a CTO leads to a number of anatomical and pathophysiological changes to the coronary circulation. These include anatomical and functional collateral vessels regression and significant lumen enlargement because of recovery of blood flow and restoration of vasomotor tone. The effect of PCI on CTO is unknown. The aim of this study was to assess the functional result of CTO PCI by measuring FFR and D SPECT before and immediately post-CTO PCI and at short-term follow-up.
Status | Not yet recruiting |
Enrollment | 150 |
Est. completion date | December 2021 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - age >18 years old - single CTO lesions, or other stenosis have been PCI treated for more than one months - the diameter of target vessel =2.5mm - stable angina pectoris, or myocardial ischemia in the area of CTO lesions - the patients agree to this research plan and sign the consent form, and complete the follow-up Exclusion Criteria: - Acute myocardial infarction in one month - In addition to the area of CTO lesions, there are serious untreated coronary lesions - bridge vascular CTO lesions - untreated coronary artery or cardiac surgery due to interventional complications, or intraoperative death - acute decompensated heart failure - allergies to contrast or radionuclide tracers - patients with planned pregnancies or lactation or 1 years after intervention - malignant neoplasms or life expectancy of less than 1 years - patients plan of surgery - patients cannot tolerate double antiplatelet therapy for at least 12 months - any condition that does not fit coronary intervention or is a drug-eluting stent |
Country | Name | City | State |
---|---|---|---|
China | Zhongshan Hospital | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Zhongshan Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | score of Seattle angina questionnaire | the result of Seattle angina questionnaire | one year | |
Primary | socre of Self-Rating Anxiety Scale | result of socre of Self-Rating Anxiety Scale | one year | |
Primary | socre of EuroQol five dimensions questionnaire | result of EuroQol five dimensions questionnaire | one year | |
Primary | Composite of cardiac death, target vessel myocardial infarction and target lesion revascularization record in follow-up | Composite of cardiac death, target vessel myocardial infarction and target lesion revascularization record in follow-up | one year | |
Primary | the success rate of Percutaneous Coronary Intervention | the success rate of Percutaneous Coronary Intervention | one year | |
Secondary | rate of cardiac death rate | rate of cardiac death rate in one year recorded in follow-up | one year | |
Secondary | rate of target vessel revascularization rate | rate of target vessel revascularization rate in one year recorded in follow-up | one year | |
Secondary | rate of recurrent myocardial infarction rate | rate of recurrent myocardial infarction rate in one year recorded in follow-up | one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |